Get Breaking Alerts on Stocks Before The Mainstream Media

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We guarantee you to keep your privacy
Connect with us
Financial Press
:-insurers-are-supposed-to-start-paying-for-covid-19-tests-starting-jan-15.-so-why-are-so-many-confused?
:-insurers-are-supposed-to-start-paying-for-covid-19-tests-starting-jan-15.-so-why-are-so-many-confused?

Breaking

: Insurers are supposed to start paying for COVID-19 tests starting Jan. 15. So why are so many confused?

Jan. 15 marks the first day that private health insurance companies will be required to reimburse policyholders for at-home COVID-19 tests they purchase, according to guidance the Biden administration published on Monday.

However, insurance companies may not have their systems up and running by then to comply with the new guidance, which was originally announced in early December but only finalized recently.

The guidance requires private insurers to cover eight rapid COVID-19 tests a month by either setting up a network of retailers so that policyholders don’t have to pay anything upfront for tests, or enabling consumers to submit receipts for reimbursement.

If the policyholder purchases a test from a retailer that is out-of-network, insurers are only required to pay up to $12 per test.

When MarketWatch reached out to several of the largest private health insurance companies — including Kaiser Permanente, Aetna
CVS,
-0.42%
,
UnitedHealth Group
UNH,
-1.33%
,
Anthem
ANTM,
-1.11%

and Cigna
CI,
+0.74%

— they couldn’t provide any details on how consumers could start getting reimbursed for tests beginning Jan. 15.

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure 🙂

“Access to testing has been a critical component of our pandemic response. We are reviewing the guidance and plan to adjust our coverage policies as appropriate,” Ethan Slavin, an Aetna spokesperson, told MarketWatch.

“We are reviewing the Biden Administration’s recent guidance on reimbursement for at-home COVID-19 tests,” said Marc Brown, a spokesperson for KaiserPermanente. “We’re working to make these tests available at no cost to our members through multiple outlets.” 

UnitedHealth declined to comment. Cigna and Anthem didn’t respond to requests for comment.

“Plans and insurers are working rapidly to determine how they will cover or reimburse over-the-counter COVID-19 tests, and may not be able to answer questions until after January 15th,” a spokeswoman for the Centers for Medicare & Medicaid Services told MarketWatch.

“If a consumer is charged for a test, the individual should keep their receipt and submit a claim to their health plan for reimbursement,” the spokeswoman added. “Consumers can find out directly from their plans how to submit reimbursement claims. Plans are not allowed to design their reimbursement process in a way that unduly delays reimbursement to a consumer.”

If you are covered by state Medicaid or Children’s Health Insurance Program (CHIP) programs, you are entitled to get at-home COVID tests without cost-sharing.

But if you are uninsured or are covered by Medicare, you can receive free tests through a forthcoming federal website or from some local community centers and pharmacies.

Written By

Click to comment

Leave a Reply

Your email address will not be published.

Related Articles

Breaking

This report has been corrected with updated data for a prior share-price decline. Verizon Communications Inc. recently offered a better-than-expected earnings outlook for the...

Breaking

An earlier version of this report misstated AT&T’s postpaid net additions. It has been corrected. A leaner AT&T Inc. topped revenue expectations Wednesday as...

Breaking

Teradyne Inc.’s first-quarter financial guidance fell short of Wall Street projections, sending shares down nearly 20% in after-hours trading to $115.03. The company projected...

Breaking

Lam Research Corp. shares plunged in late trading Wednesday after the chip-equipment supplier reported worse-than-expected fiscal second-quarter revenue and third-quarter guidance, which the chief...

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure :)

Get Breaking Stock Alerts

Email address

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address